» Articles » PMID: 3781620

Use of a Monoclonal Antibody to Determine the Mode of Transmembrane Pore Formation by Streptolysin O

Overview
Journal Infect Immun
Date 1986 Dec 1
PMID 3781620
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Murine monoclonal antibodies were generated against streptolysin O. One out of 10 tested immunoglobulin clones exhibited strong neutralizing activity; in solution, the presence of approximately two to four antibody molecules per toxin monomer effected 50% neutralization of hemolytic toxin activity. An enzyme-linked immunosorbent assay performed with target cell membranes that were treated with streptolysin O in the presence and absence of neutralizing antibodies showed that the antibodies did not block primary binding of the toxin to the cells. When membranes were solubilized in deoxycholate detergent and centrifuged in sucrose density gradients, those lysed with streptolysin O contained detergent-resistant, high-molecular-weight oligomers identical to the pore lesions, whereas those given toxin and neutralizing antibody contained the toxin exclusively in low-molecular-weight, nonoligomerized form. The process of pore formation by streptolysin O must thus involve two distinct steps, i.e., the primary binding of toxin molecules to the membrane followed by oligomerization of bound toxin monomers by lateral aggregation in the lipid bilayer to form the transmembrane pores.

Citing Articles

Cholesterol dependent cytolysins and the brain: Revealing a potential therapeutic avenue for bacterial meningitis.

Pramitasuri T, Susilawathi N, Tarini N, Sudewi A, Evans M AIMS Microbiol. 2024; 9(4):647-667.

PMID: 38173970 PMC: 10758573. DOI: 10.3934/microbiol.2023033.


Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity.

Kucinskaite-Kodze I, Simanavicius M, Dapkunas J, Pleckaityte M, Zvirbliene A Biomolecules. 2020; 10(7).

PMID: 32650398 PMC: 7408604. DOI: 10.3390/biom10071009.


Inhibition of Pore-Forming Proteins.

Omersa N, Podobnik M, Anderluh G Toxins (Basel). 2019; 11(9).

PMID: 31546810 PMC: 6784129. DOI: 10.3390/toxins11090545.


Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration.

Feil S, Ascher D, Kuiper M, Tweten R, Parker M J Mol Biol. 2013; 426(4):785-92.

PMID: 24316049 PMC: 4323271. DOI: 10.1016/j.jmb.2013.11.020.


Intact Golgi synthesize complex branched O-linked chains on glycoside primers: evidence for the functional continuity of seven glycosyltransferases and three sugar nucleotide transporters.

Kim S, Miura Y, Etchison J, Freeze H Glycoconj J. 2002; 18(8):623-33.

PMID: 12376727 DOI: 10.1023/a:1020691619908.


References
1.
Dourmashkin R, Rosse W . Morphologic changes in the membranes of red blood cells undergoing hemolysis. Am J Med. 1966; 41(5):699-710. DOI: 10.1016/0002-9343(66)90031-3. View

2.
Menestrina G . Ionic channels formed by Staphylococcus aureus alpha-toxin: voltage-dependent inhibition by divalent and trivalent cations. J Membr Biol. 1986; 90(2):177-90. DOI: 10.1007/BF01869935. View

3.
SMYTH C, FREER J, Arbuthnott J . Interaction of Clostridium perfringens theta-haemolysin, a contaminant of commercial phospholipase C, with erythrocyte ghost membranes and lipid dispersions. A morphological study. Biochim Biophys Acta. 1975; 382(4):479-93. DOI: 10.1016/0005-2736(75)90216-3. View

4.
Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

5.
Duncan J, Schlegel R . Effect of streptolysin O on erythrocyte membranes, liposomes, and lipid dispersions. A protein-cholesterol interaction. J Cell Biol. 1975; 67(1):160-74. PMC: 2109585. DOI: 10.1083/jcb.67.1.160. View